A first-in-human phase I study to determine the maximum tolerated dose of the oral Src/ABL inhibitor AZD0424

A first-in-human phase I study to determine the maximum tolerated dose of the oral Src/ABL inhibitor AZD0424

A first-in-human phase I study to determine the maximum tolerated dose of the oral Src/ABL inhibitor AZD0424, Published online: 13 February 2018; doi:10.1038/bjc.2017.484

A first-in-human phase I study to determine the maximum tolerated dose of the oral Src/ABL inhibitor AZD0424

from Cancer via ola Kala on Inoreader http://ift.tt/2GamEz8
via IFTTT